Biomarkers US 2023

Day One Tracks:

Biomarkers in Drug Discovery & Translational Sciences

Biomarkers for Precision Medicine & Diagnostic Development

Biomarkers for Clinical Development

Day Two Tracks: 

Biomarker Analysis & Emerging Technologies

Omic Approaches in Precision Medicine and Clinical Development

View the agenda here: https://www.oxfordglobal.co.uk/biomarkers-series-us/agenda/download-agenda/?utm_source=hummolgen&utm_medium=eventlisting&utm_campaign=biomarkers&utm_content=biomus2023

Co-located with Immuno US 2023 attendees get access to both events. For more information contact marketing@oxfordglobal.co.uk

Meet Key Decision makers representing large pharma & biotech companies:

I-Ming Wang (Director, Translational Oncology, Pfizer)

Matthias Von Herrath (Vice President, Novo Nordisk)

Siddha Kasar (Director, Translational Lead, Takeda Pharmaceuticals)

Sandor Szalma (Global Head of Genetics and Systems Biology, Takeda)

Amanda Klein (Executive Director, Translant Therapeutics Consortium, Critical Path Institute)

View the full list of speakers here: https://www.oxfordglobal.co.uk/biomarkers-series-us/speakers/